COL1A1 and ischemia reperfusion injury: Both miR-335-3p and miR-338-3p have been shown to protect the myocardium against ischemia-reperfusion injury (68) and prevent fibrosis by inhibiting cell proliferation and migration of cardiac fibroblasts as well as reducing Col1a1 expression (69).